Pertussis Outbreak During 2023 in Gipuzkoa, North Spain
Author
Date
2024-10-18Permanent link
https://hdl.handle.net/11351/12331DOI
10.3390/vaccines12101192
ISSN
2076-393X
WOS
001343549000001
PMID
39460357
Abstract
Background: Pertussis has re-emerged in many countries despite the wide use of vaccines for over 60 years. During 2023, we observed an increase in the incidence of pertussis in Gipuzkoa, north of Spain (with a population of 657,140 inhabitants), mainly affecting children between 11 and 15 years of age.
Methods: This study included all confirmed cases diagnosed by PCR in nasopharyngeal swab samples. The genome of seven isolates collected in 2023 was sequenced.
Results: Between 2018 and 2023, 884 cases of whooping cough were diagnosed. Pertussis incidence (in cases per 100,000 inhabitants) decreased from 36.7 in 2018 to no cases in 2021, increasing again to 56.8 in 2023. In 2023, the age group of 11-15 years old had the highest incidence rate of 409.3. Only 2 of the 56 children < 6 years old required hospitalization, and there were no deaths. The seven isolates collected in 2023 showed the same BPagST-4 (ptxA1/ptxP3/prn2/fim2-1/fim3-1 allelic combination), with all of them expressing the pertactin antigen.
Conclusions: Immunity waning after the last dose of vaccination at 6 years old, together with the lack of circulation of Bordetella pertussis during the COVID-19 pandemic, were probably the main reasons for the high increase in the incidence of pertussis in Gipuzkoa in 2023.
Keywords
Bordetella pertussis; Outbreak; VaccinationBibliographic citation
Marimón JM, Montes M, Vizuete N, Alvarez Guerrico L, Aginagalde AH, Mir-Cros A, et al. Pertussis Outbreak During 2023 in Gipuzkoa, North Spain. Vaccines (Basel). 2024 Oct 18;12(10):1192.
Audience
Professionals
This item appears in following collections
- HVH - Articles científics [4476]
The following license files are associated with this item:





